Ondansetron ODT 8 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FQAHP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,664
Award facts
- Contract value 100% obligated
- $3,664.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on August 5, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This contract, valued at $3,664.15 with an ultimate completion date of August 6, 2025, carries no set-aside designation and represents a single delivery order under the DLA's broader pharmaceutical supply framework. The place of performance is located in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA's SPE2DB program, a $500 million vehicle valid through November 2026 that enables the procurement of comprehensive pharmaceutical products supporting military health facilities worldwide. The Ondansetron ODT tablets, an antiemetic medication commonly used in healthcare settings, exemplify the type of prescription pharmaceutical products the company routinely supplies to Department of Defense medical facilities. DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain is reinforced through this award, demonstrating the company's continued capacity to deliver essential medications to military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FQAHP?
SPE2DB25FQAHP was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FQAHP worth?
The government has obligated $3,664 on SPE2DB25FQAHP.
Is contract SPE2DB25FQAHP an order under another contract?
Yes. SPE2DB25FQAHP is a delivery order under SPE2DB25D9305, an indefinite delivery contract.
Was contract SPE2DB25FQAHP competed?
The extent of competition for SPE2DB25FQAHP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award